Webinars
MDoutlook® Delivers Precision Intelligence
Upcoming Webinar:
Unlocking the Power of Pulse Research
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
November 18, 2021
Previous Webinars:
No post found
Our 2019 Leadership study in ImmunoOncology shows that 1 in 3 oncologists (across the US and EU) are not sufficiently aware of different patient support programs. While oncologists most often recall the patient support programs by BMS, Roche/Genentech and Merck there is no overall corporate leader. Patient support programs can
Read more
Having revealed the top attributes for successful leadership in ImmunoOncology, MDOutlook’s latest release reveals that specific commercial and marketing activities influence about 25% of oncologists’ leadership criteria. As important criteria for steering successful leadership reputation, oncologists rated the following specific commercial and marketing activities in order of impact. Length of
Read more
In our latest release from the 2019 Leadership study, we reveal 7 key attributes that account for 75% of Oncologists' definition of leadership in ImmunoOncology (IO). These attributes comprise R&D / pipeline and product related aspects of life science company activities. We found high consistency across geography. However, EU oncologists
Read more
Later this month, MDOutlook will release results from the latest wave of their global leadership study. Using ONCpulse™, we engaged with a robust sample of oncologists located in the United States and Europe. The research objectives were to: Define the meaning of “corporate leadership” to the oncology community Reveal the
Read more
ONCpulse™ recently provided time sensitive feedback from Oncologists’ review of messaging from a TPP project in metastatic Gastric Cancer. Reflecting on the study, the Director of Market Research Oncology of this large biopharmaceutical client reported (Jan 2019): “This is great! Thanks. I appreciate the quick turnaround and will discuss the
Read more
Since 1901 the Nobel Prize for Physiology and Medicine has been awarded to 216 Laureates. In total, 122 different discoveries have been endowed; 36 of which directly or indirectly related to cancer development and treatment [source: Team Analysis]. We are excited that the Nobel Assembly at the Karolinska Institute recognizes the
Read more
Two very common questions we are often asked by our clients are “What is a typical patient volume for this disease?” and “Who are the high-volume treaters?” Recently, we performed an analysis of nearly 1300 U.S. physician-reported recent patient volumes in selected GI tumor types, leading to interesting insights. In
Read more
For 10+ years, MDOutlook has been helping clients to fight the battle to better understand how new clinical data drives treatment decisions. Early this summer, we completed a study that exemplifies how a data presentation at major medical meeting impacts oncologists’ treatment decisions. As shown in Figure 1, we project
Read more
The goal of ONCpulse™ is to provide rapid insights to your customized questions. We greatly appreciate recent feedback received from our clients: "Thank you so much. That was a quick turnaround, which is great!" - VP, Healthcare Communications Agency "Excellent turnaround, thanks!" - Chief Commercial Officer, Strategic Consultancy Read below
Read more
We are thrilled to announce the launch of our newest subscription service: ONCpulse™. Realizing that many of our clients struggle with obtaining rapid insights to improve their decision-making, MDOutlook has developed ONCpulse. ONCpulse delivers rapid, on-demand insights from verified, high quality cancer treaters and experts: Rapid: Delivering actionable insights within
Read more
Archives
[archives type=monthly limit=10]
Links
FDA Drug information:
http://www.fda.gov/Drugs
European Medicines Agency:
http://www.ema.europa.eu/
Publication Research:
http://www.ncbi.nlm.nih.gov/pubmed
Clinical Trials Research:
http://www.clinicaltrials.gov/